Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:insurance
|
| gptkbp:alternativeName |
ATC_code_group
Anatomical_Therapeutic_Chemical_(ATC)_code Anatomical_Therapeutic_Chemical_Classification_System_code |
| gptkbp:appliesTo |
human medicines
veterinary medicines |
| gptkbp:example |
N02BE01 (Paracetamol)
|
| gptkbp:fifthBook |
gptkb:chemical_compound
|
| gptkbp:fourthLevel |
chemical subgroup
|
| gptkbp:hasComponent |
ATC code structure
|
| gptkbp:hasVersion |
ATCvet code
|
| https://www.w3.org/2000/01/rdf-schema#label |
ATC code
|
| gptkbp:introducedIn |
1976
|
| gptkbp:level |
anatomical main group
5 levels |
| gptkbp:maintainedBy |
gptkb:World_Health_Organization
|
| gptkbp:publishedBy |
gptkb:WHO_Collaborating_Centre_for_Drug_Statistics_Methodology
|
| gptkbp:relatedTo |
Defined Daily Dose (DDD)
|
| gptkbp:secondLevelDomains |
therapeutic subgroup
|
| gptkbp:thirdLevel |
pharmacological subgroup
|
| gptkbp:usedFor |
classification of drugs
|
| gptkbp:usedIn |
gptkb:medicine
gptkb:pharmacy |
| gptkbp:bfsParent |
gptkb:A06AD15
gptkb:J07AL |
| gptkbp:bfsLayer |
5
|